Vitamin D and disability in relapsing–remitting multiple sclerosis in patients with a Mexican background

被引:0
|
作者
Yamel Rito
Jesus Flores
Angeles Fernández-Aguilar
Carmen Escalante-Membrillo
Miguel A. Barboza
Lilyana Amezcua
Teresa Corona
机构
[1] Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez,
[2] MS Comprehensive Care Center,undefined
[3] University of Southern California (USC),undefined
来源
Acta Neurologica Belgica | 2018年 / 118卷
关键词
Relapsing–remitting multiple sclerosis; Vitamin D; Disability; Mexicans;
D O I
暂无
中图分类号
学科分类号
摘要
Previous studies of multiple sclerosis (MS) patients have reported an inverse correlation between disability, the number of relapses and vitamin D levels in mostly white patients. It is unclear if this relationship has the same behavior in individuals with Hispanic backgrounds. To determine the relationship between vitamin D serum levels and disability in a sample of Hispanics of a Mexican background with relapsing–remitting multiple sclerosis (RRMS). A cross-sectional study was conducted on 50 RRMS individuals of Mexican background. The Expanded Disability Status Scale (EDSS) score, progression index (PI) and annual relapse rate (ARR) were recorded for each patient. Vitamin D levels were assessed during the summer. Pearson’s test was used to evaluate the relationship between vitamin D and EDSS, PI, ARR, and duration of disease evolution. Most patients were females (n = 29, 58%). The mean vitamin D level was 22.3 (± 6.4) ng/ml; the mean EDSS score was 2.2 (± 0.7), ARR 1.3 (± 0.5) and PI1.08 (± 0.6). No correlation was found between vitamin D levels and EDSS scores, ARR, PI or duration of disease. Moderate negative association between vitamin D levels and EDSS was found just in females (<0.0001). No correlation between vitamin D levels and disability was found in this sample of RRMS Mexicans. Longitudinal studies are needed to better understand the impact of Vitamin D in disability and multiple time points.
引用
收藏
页码:47 / 52
页数:5
相关论文
共 50 条
  • [21] Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
    Holmoy, Trygve
    Torkildsen, Oivind
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (03) : 233 - 235
  • [22] Clinical disability and slowly expanding lesions in relapsing remitting multiple sclerosis patients
    Bao, Fen
    Bross, Madeline
    Lichtman-Mikol, Samuel
    Hackett, Melody
    Santiago-Martinez, Carla
    Rube, Jacob
    Srivastava, Samiksha
    Bernitsas, Evanthia
    [J]. NEUROLOGY, 2021, 96 (15)
  • [23] Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis
    Doche, Emilie
    Lecocq, Angele
    Maarouf, Adil
    Duhamel, Guillaume
    Soulier, Elisabeth
    Confort-Gouny, Sylviane
    Rico, Audrey
    Guye, Maxime
    Audoin, Bertrand
    Petletier, Jean
    Ranjeva, Jean-Philippe
    Zaaraoui, Wafaa
    [J]. JOURNAL OF NEURORADIOLOGY, 2017, 44 (02) : 158 - 164
  • [24] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [25] Vitamin D and disability in multiple sclerosis patients
    Niedziela, N.
    Niedziela, J.
    Pierzchala, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 720 - 720
  • [26] EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature
    Nejati, Ahmad
    Shoja, Zabihollah
    Shahmahmoodi, Shohreh
    Tafakhori, Abbas
    Mollaei-Kandelous, Yaghoub
    Rezaei, Farhad
    Hamid, Kabir Magaji
    Mirshafiey, Abbas
    Doosti, Rozita
    Sahraian, Mohammad Ali
    Mahmoudi, Mahmood
    Shokri, Fazel
    Emery, Vince
    Marashi, Sayed Mahdi
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2016, 205 (02) : 143 - 154
  • [27] Is serum vitamin D levels associated with clinical course of disease in patients with relapsing remitting multiple sclerosis?
    Efendi, H.
    Bunul, S. D.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 247 - 247
  • [28] EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature
    Ahmad Nejati
    Zabihollah Shoja
    Shohreh Shahmahmoodi
    Abbas Tafakhori
    Yaghoub Mollaei-Kandelous
    Farhad Rezaei
    Kabir Magaji Hamid
    Abbas Mirshafiey
    Rozita Doosti
    Mohammad Ali Sahraian
    Mahmood Mahmoudi
    Fazel Shokri
    Vince Emery
    Sayed Mahdi Marashi
    [J]. Medical Microbiology and Immunology, 2016, 205 : 143 - 154
  • [29] The effect of tobacco use on retinal structures in vitamin d deficient patients with relapsing remitting multiple sclerosis
    Gilroy, M.
    Darling, R.
    Lichtman-Mikol, S.
    Razmjou, S.
    Probst-Simmons, E.
    Santiago-Martinez, C.
    Bernitsas, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 233 - 234
  • [30] Baseline vitamin D levels and multiple sclerosis activity in relapsing-remitting patients treated with fingolimod
    Ferre, L.
    Sferruzza, G.
    Mascia, E.
    Clarelli, F.
    Dalla Costa, G.
    Radaelli, M.
    Sangalli, F.
    Nuara, A.
    Guaschino, C.
    Rocca, M. A.
    Filippi, M.
    Boneschi, F. Martinelli
    Comi, G.
    Martinelli, V.
    Esposito, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 500 - 501